Leibovitch SA - Search Results

1

MD11-mediated delivery of recombinant eIF3f induces melanoma and colorectal carcinoma cell death.

Marchione R, Laurin D, Liguori L, Leibovitch MP, Leibovitch SA, Lenormand JL. Marchione R, et al. Among authors: leibovitch sa. Mol Ther Methods Clin Dev. 2015 Feb 4;2:14056. doi: 10.1038/mtm.2014.56. eCollection 2015. Mol Ther Methods Clin Dev. 2015. PMID: 26052528 Free PMC article.

2

The translational factor eIF3f: the ambivalent eIF3 subunit.

Marchione R, Leibovitch SA, Lenormand JL. Marchione R, et al. Among authors: leibovitch sa. Cell Mol Life Sci. 2013 Oct;70(19):3603-16. doi: 10.1007/s00018-013-1263-y. Epub 2013 Jan 25. Cell Mol Life Sci. 2013. PMID: 23354061 Free PMC article. Review.

3

eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy.

Csibi A, Tintignac LA, Leibovitch MP, Leibovitch SA. Csibi A, et al. Among authors: leibovitch sa. Cell Cycle. 2008 Jun 15;7(12):1698-701. doi: 10.4161/cc.7.12.6090. Epub 2008 Jun 11. Cell Cycle. 2008. PMID: 18583931

4

The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.

Lagirand-Cantaloube J, Offner N, Csibi A, Leibovitch MP, Batonnet-Pichon S, Tintignac LA, Segura CT, Leibovitch SA. Lagirand-Cantaloube J, et al. Among authors: leibovitch sa. EMBO J. 2008 Apr 23;27(8):1266-76. doi: 10.1038/emboj.2008.52. Epub 2008 Mar 20. EMBO J. 2008. PMID: 18354498 Free PMC article.

5

Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.

Lagirand-Cantaloube J, Cornille K, Csibi A, Batonnet-Pichon S, Leibovitch MP, Leibovitch SA. Lagirand-Cantaloube J, et al. Among authors: leibovitch sa. PLoS One. 2009;4(3):e4973. doi: 10.1371/journal.pone.0004973. Epub 2009 Mar 25. PLoS One. 2009. PMID: 19319192 Free PMC article.

6

Mos activates myogenic differentiation by promoting heterodimerization of MyoD and E12 proteins.

Lenormand JL, Benayoun B, Guillier M, Vandromme M, Leibovitch MP, Leibovitch SA. Lenormand JL, et al. Among authors: leibovitch sa, leibovitch mp. Mol Cell Biol. 1997 Feb;17(2):584-93. doi: 10.1128/MCB.17.2.584. Mol Cell Biol. 1997. PMID: 9001211 Free PMC article.

7

MyoD binds to Mos and inhibits the Mos/MAP kinase pathway.

Solhonne B, Lenormand JL, Pelpel K, Leibovitch MP, Leibovitch SA. Solhonne B, et al. Among authors: leibovitch sa, leibovitch mp. FEBS Lett. 1999 Nov 12;461(1-2):107-10. doi: 10.1016/s0014-5793(99)01430-1. FEBS Lett. 1999. PMID: 10561505 Free article.

8

Signal-induced ubiquitination of p57(Kip2) is independent of the C-terminal consensus Cdk phosphorylation site.

Leibovitch MP, Kannengiesser C, Leibovitch SA. Leibovitch MP, et al. Among authors: leibovitch sa. FEBS Lett. 2003 May 22;543(1-3):125-8. doi: 10.1016/s0014-5793(03)00425-3. FEBS Lett. 2003. PMID: 12753918 Free article.

9

Muscle regulatory factor MRF4 activates differentiation in rhabdomyosarcoma RD cells through a positive-acting C-terminal protein domain.

Sirri V, Leibovitch MP, Leibovitch SA. Sirri V, et al. Among authors: leibovitch sa, leibovitch mp. Oncogene. 2003 Aug 28;22(36):5658-66. doi: 10.1038/sj.onc.1206690. Oncogene. 2003. PMID: 12944914

10

Identification of a novel regulatory element in the c-mos locus that activates transcription in somatic cells.

Lenormand JL, Leibovitch SA. Lenormand JL, et al. Among authors: leibovitch sa. Biochem Biophys Res Commun. 1995 May 5;210(1):181-8. doi: 10.1006/bbrc.1995.1644. Biochem Biophys Res Commun. 1995. PMID: 7741739

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

70 results

Search Page